# HLA-B27, Mantoux Test, and Eosinophil Count: Help in the Diagnosis of Reactive Arthritis Due to Tubercular Hypersensitivity

**Authors:** Akshita Makkar, Venkatesh S Pai, Prasan K Panda

PMC · DOI: 10.7759/cureus.95386 · Cureus · 2025-10-25

## TL;DR

A case study explores how HLA-B27, Mantoux test, and eosinophil count can aid in diagnosing reactive arthritis linked to tuberculosis hypersensitivity.

## Contribution

Highlights the diagnostic value of HLA-B27, Mantoux positivity, and eosinophilia in TB-related reactive arthritis.

## Key findings

- HLA-B27-associated reactive arthritis can manifest with polyarthritis and pleural effusion.
- Mantoux positivity and eosinophilia may indicate TB hypersensitivity despite normal ADA and negative CBNAAT.
- NSAIDs and TB preventive therapy improved symptoms, suggesting immune-mediated inflammation.

## Abstract

Reactive arthritis (ReA) is a form of inflammatory arthritis usually triggered by gastrointestinal/genitourinary infections. We present the case of a middle-aged man with HLA-B27-associated ReA and tuberculosis (TB) hypersensitivity, manifesting as polyarthritis, inflammatory low back pain, and pleural effusion. The patient had a three-year history of progressive joint pain, initially involving the knees, followed by the bilateral ankle joints and small joints of the hands, wrists, shoulders, elbows, and axial skeleton. He also had a prolonged fever with an exudative pleural effusion, eosinophilia, and Mantoux positivity, though pleural fluid adenosine deaminase (ADA) and cartridge-based nucleic acid amplification test (CBNAAT) were within normal limits and negative, respectively. Due to the autoimmune-inflammatory overlap, treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) resulted in rapid improvement in joint pains, and tuberculosis preventive therapy was initiated to prevent TB reactivation. The case highlights the complex interaction between immune-mediated inflammation and TB hypersensitivity, emphasizing the need for careful differential diagnosis and treatment plans in seronegative arthritis with systemic features.

## Linked entities

- **Diseases:** reactive arthritis (MONDO:0017376), tuberculosis (MONDO:0018076)

## Full-text entities

- **Genes:** HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}
- **Diseases:** fever (MESH:D005334), Tubercular Hypersensitivity (MESH:D014390), gastrointestinal/genitourinary infections (MESH:D014565), autoimmune-inflammatory (MESH:D007249), pleural effusion (MESH:D010996), inflammatory arthritis (MESH:D001168), joint pain (MESH:D018771), ReA (MESH:D016918), inflammatory low back pain (MESH:D017116), eosinophilia (MESH:D004802), TB hypersensitivity (MESH:D014376)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12642823/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12642823/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12642823/full.md

---
Source: https://tomesphere.com/paper/PMC12642823